These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3576015)

  • 1. Effect of covariate measurement error in randomized clinical trials.
    Morgan TM; Elashoff RM
    Stat Med; 1987; 6(1):31-41. PubMed ID: 3576015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiparametric estimation of proportional mean residual life model in presence of censoring.
    Chen YQ; Jewell NP; Lei X; Cheng SC
    Biometrics; 2005 Mar; 61(1):170-8. PubMed ID: 15737090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient heterogeneity and the need for randomized clinical trials.
    Green SB
    Control Clin Trials; 1982 Sep; 3(3):189-98. PubMed ID: 7151437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored.
    Cécilia-Joseph E; Auvert B; Broët P; Moreau T
    Biom J; 2015 May; 57(3):371-83. PubMed ID: 25597640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of misclassification on covariate-adaptive randomized clinical trials.
    Wang T; Ma W
    Biometrics; 2021 Jun; 77(2):451-464. PubMed ID: 32453885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
    Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the efficiency of clinical trials: a medical perspective.
    Moertel CG
    Stat Med; 1984; 3(4):455-68. PubMed ID: 6528139
    [No Abstract]   [Full Text] [Related]  

  • 9. Fully parametric and semi-parametric regression models for common events with covariate measurement error in main study/validation study designs.
    Spiegelman D; Casella M
    Biometrics; 1997 Jun; 53(2):395-409. PubMed ID: 9192443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of constrained block allocation sequences.
    Salama I; Ivanova A; Qaqish B
    Stat Med; 2008 Apr; 27(9):1421-8. PubMed ID: 17729381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laplace regression with censored data.
    Bottai M; Zhang J
    Biom J; 2010 Aug; 52(4):487-503. PubMed ID: 20680972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural inference in transition measurement error models for longitudinal data.
    Pan W; Lin X; Zeng D
    Biometrics; 2006 Jun; 62(2):402-12. PubMed ID: 16918904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nonparametric approach for baseline covariate adjustment for two-group comparative studies.
    Schacht A; Bogaerts K; Bluhmki E; Lesaffre E
    Biometrics; 2008 Dec; 64(4):1110-6. PubMed ID: 18266888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of covariate omission in Weibull accelerated failure time model: a caution.
    Gosho M; Maruo K; Sato Y
    Biom J; 2014 Nov; 56(6):991-1000. PubMed ID: 24895154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of stratum-covariate interactions in Cox's proportional hazards regression model.
    Thall PF; Lachin JM
    Stat Med; 1986; 5(1):73-83. PubMed ID: 3515475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment allocation for nonlinear models in clinical trials: the logistic model.
    Begg CB; Kalish LA
    Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic treatment allocation adjusting for prognostic factors for more than two treatments.
    Dror S; Faraggi D; Reiser B
    Biometrics; 1995 Dec; 51(4):1338-43. PubMed ID: 8589225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing apparent treatment--covariate interactions in randomized clinical trials.
    Byar DP
    Stat Med; 1985; 4(3):255-63. PubMed ID: 4059716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating surrogate markers of clinical outcome when measured with error.
    Dafni UG; Tsiatis AA
    Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy in lung cancer.
    Souhami RL
    Chest; 1989 Jul; 96(1 Suppl):66S-68S. PubMed ID: 2544367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.